tirofiban has been researched along with Neointima in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, B; Li, D; Li, F; Liu, K; Liu, X; Lu, H; Lu, X; Qiu, P; Yin, M; Zhao, Z | 1 |
1 other study(ies) available for tirofiban and Neointima
| Article | Year |
|---|---|
Near-infrared -triggered release of tirofiban from nanocarriers for the inhibition of platelet integrin αIIbβ3 to decrease early-stage neointima formation.
Topics: Animals; Blood Platelets; Drug Carriers; Infrared Rays; Mice; Mice, Knockout, ApoE; Nanoparticles; Neointima; Platelet Glycoprotein GPIIb-IIIa Complex; RAW 264.7 Cells; Tirofiban | 2020 |